Adrenergic neurohumoral influences on circulation and lipolysis in canine omental adipose tissue.
D000273:Adipose Tissue / Q000098:blood supply* / Q000378:metabolism*; D000818:Animals; D001810:Blood Volume / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D004285:Dogs; D004558:Electric Stimulation; D004878:Ergotamine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005990:Glycerol / Q000378:metabolism; D007456:Iodine Isotopes; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D009852:Omentum; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011955:Receptors, Drug; D012039:Regional Blood Flow; D013564:Sympathetic Nervous System / Q000502:physiology*; D014655:Vascular Resistance / Q000187:drug effects
D005230:Fatty Acids, Nonesterified; D007456:Iodine Isotopes; D011955:Receptors, Drug; D011433:Propranolol; D005990:Glycerol; D004878:Ergotamine; D009638:Norepinephrine; D010646:Phentolamine